evjgs-9z5uh

Hökmdar

• Speaker 1 1:20
• Speaker 2 13:19
• Speaker 3 36:12

1. 1:20

   Bölmə 1: Of course, I just read, there are two ReDME files also inside, but I think it's not relevant. 301s · Speaker 1

   Of course, I just read, there are two ReDME files also inside, but I think it's not relevant. Maybe they mention some more genotypes and some mutant also. Inside the ReDME file? Inside the file that I show you. This one? So, this is the wil…

2. 6:21

   Bölmə 2: data, like we can only. 237s · Speaker 1

   data, like we can only... The only thing that we can take from this data is we can only see the genes which are more active, like they are, their expression level is high in G2 phase, so we can... Yes, there are a lot of, so there are actua…

3. 11:22

   Bölmə 3: that we can take. 117s · Speaker 1

   that we can take. So this is a comparative analysis of that much of certain tissues. And yeah, so we can, you know, compare a few tissues that we're pretty sure that they don't have, well, that they're not doing mouses. And there are a lot …

4. 13:19

   Bölmə 4: download all the files and all the data for the transcriptome before the preview So, I guess, I guess adult leave, you know, just compare those with adult leave and then you don't have to leave. 312s · Speaker 2

   download all the files and all the data for the transcriptome before the preview So, I guess, I guess adult leave, you know, just compare those with adult leave and then you don't have to leave. So that's that, that's that. And then to incr…

5. 18:32

   Bölmə 5: diagnosis, in the diagnosis actually can still be observed at the really late stages. 96s · Speaker 1

   diagnosis, in the diagnosis actually can still be observed at the really late stages. And so I am saying that pectin might not be easy to know the distribution. And maybe the stages, defaulting or dikenesis could be easier to look at. And a…

6. 20:08

   Bölmə 6: yeah, I, yeah. 302s · Speaker 2

   yeah, I, yeah. This is just segmentation. Yeah. We already have. So, no, no, no, from the beginning. I, I like. Okay. So, yeah, no, no, I, yeah. So, for M1. So, this is sub M1. Yeah, I know. Okay, I need to go behind. Uh, no, no, so determi…

7. 25:10

   Bölmə 7: not good, well, cannot penetrate that much if you have a better self, especially for this one. 300s · Speaker 1

   not good, well, cannot penetrate that much if you have a better self, especially for this one. This is nucleolus, it's fine. This is nucleolus, but those two looks like the antibody didn't penetrate well. See, or maybe in portraiture will b…

8. 30:11

   Bölmə 8: So you will do this calculation to measure the interference and distribution? 301s · Speaker 1

   So you will do this calculation to measure the interference and distribution? Yeah, interference and distribution, yes, we can do that. So then, this is for the... I did some paper of a time for the coffee. Right, right, right. But how are …

9. 35:13

   Bölmə 9: I will map it on the e730 reference genome and then because we already have a similar line which will be sent then we can So we can see like which region has more MHS motifs, how many region has both, how many region has this one, and any of these have overlap with the variations data, SNPs or other SNPs data. 302s · Speaker 2

   I will map it on the e730 reference genome and then because we already have a similar line which will be sent then we can So we can see like which region has more MHS motifs, how many region has both, how many region has this one, and any o…

10. 40:15

    Bölmə 10: yeah so then we can just determine whether increase restoration so for this we also use F1 for RNA sequence we will do and so we have two options like if we have very few genes like 5 or 10 genes from M1 and M2 then we just simply do RTP so if we have multiple genes and we didn't find any gene then we will do RNA sequence okay I would like to suggest that From the M1 and M2, we will know, for example, like, one, what stage is this affected? 300s · Speaker 2

    yeah so then we can just determine whether increase restoration so for this we also use F1 for RNA sequence we will do and so we have two options like if we have very few genes like 5 or 10 genes from M1 and M2 then we just simply do RTP so…

11. 45:16

    Bölmə 11: okay, if we found the genomic features, and then what can we do? 88s · Speaker 1

    okay, if we found the genomic features, and then what can we do? If we found... Well, you already mentioned that, I mean, the hepatitis. And then if we found... Actually, I think if we found some target gene shows really different expressio…

12. 46:45

    Bölmə 12: There's one more option I'm thinking. 300s · Speaker 2

    There's one more option I'm thinking. Like if we do NGS for this one, F1 hybrid, we can sequence it. So we can compare B7, because we already have a sequence of B7, B7 and CMI2 to it in M9. And if we compare this, we can see variations that…

13. 51:45

    Bölmə 13: Good, and, and, okay. 309s · Speaker 1

    Good, and, and, okay. All right, so send me the introduction, and then we can meet again next week. Confirm? Yeah, confirm. I'm not sorry. There's something done. No, not sometimes. Chilomere bouquet is different. Chilomere bouquet? Yes. Ok…

14. 56:55

    Bölmə 14: next meeting is? 60s · Speaker 1

    next meeting is? Next, next, next, next. Can we fix the permanent meeting? Yeah, we can do everything. But before QE, we need more? Yeah. We can schedule next meeting when I will do it. Okay. Tuesday 2? This 2? Next 2? No. Next Friday is my…